JNJ

170.71

-0.01%↓

ABBV

196.37

-1.09%↓

AZN

73.59

-1.13%↓

NVS

113.55

-3.58%↓

ABT

130.95

+0.14%↑

JNJ

170.71

-0.01%↓

ABBV

196.37

-1.09%↓

AZN

73.59

-1.13%↓

NVS

113.55

-3.58%↓

ABT

130.95

+0.14%↑

JNJ

170.71

-0.01%↓

ABBV

196.37

-1.09%↓

AZN

73.59

-1.13%↓

NVS

113.55

-3.58%↓

ABT

130.95

+0.14%↑

JNJ

170.71

-0.01%↓

ABBV

196.37

-1.09%↓

AZN

73.59

-1.13%↓

NVS

113.55

-3.58%↓

ABT

130.95

+0.14%↑

JNJ

170.71

-0.01%↓

ABBV

196.37

-1.09%↓

AZN

73.59

-1.13%↓

NVS

113.55

-3.58%↓

ABT

130.95

+0.14%↑

Phreesia Inc

Затворен

СекторЗдравеопазване

27.09 0.11

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

26.8

Максимум

28.27

Ключови измерители

By Trading Economics

Приходи

2.5M

-3.9M

Продажби

6.3M

116M

Марж на печалбата

-3.376

Служители

2,082

EBITDA

2M

4.1M

Препоръки

By TipRanks

Препоръки

Силна покупка

12-месечна прогноза

+17.3% upside

Дивиденти

By Dow Jones

Следващи печалби

3.09.2025 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

193M

1.6B

Предишно отваряне

26.98

Предишно затваряне

27.09

Настроения в новините

By Acuity

29%

71%

76 / 374 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Neutral Evidence

Phreesia Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

6.08.2025 г., 22:24 ч. UTC

Печалби
Значими двигатели на пазара

Airbnb Logs 2Q Beat, But Investments Weigh on Margin Outlook -- Update

6.08.2025 г., 23:43 ч. UTC

Пазарно говорене

Nikkei May Decline Amid Uncertainty Over Earnings, U.S. Tariffs -- Market Talk

6.08.2025 г., 23:39 ч. UTC

Пазарно говорене

Gold Steady as Traders Assess Geopolitical, Tariff Developments -- Market Talk

6.08.2025 г., 23:28 ч. UTC

Печалби

Kakao 2Q Net Profit Beat FactSet-Compiled Consensus

6.08.2025 г., 23:28 ч. UTC

Печалби

Kakao 2Q Net KRW171.82B Vs. Net KRW87.15B >035720.SE

6.08.2025 г., 23:28 ч. UTC

Печалби

Kakao 2Q Oper Pft KRW185.93B Vs. Pft KRW133.96B >035720.SE

6.08.2025 г., 23:28 ч. UTC

Печалби

Kakao 2Q Rev KRW2.028T Vs. KRW2.005T >035720.SE

6.08.2025 г., 23:14 ч. UTC

Печалби

Fiserv, Shift4, Toast Stocks Tumble on Earnings. Analysts Are Optimistic Anyway. -- Barrons.com

6.08.2025 г., 23:01 ч. UTC

Печалби

United Overseas Bank 2Q Net Interest Income S$2.34B Vs. S$2.40B >U11.SG

6.08.2025 г., 23:01 ч. UTC

Печалби

United Overseas Bank 2Q Total Income S$3.47B Vs. S$3.48B >U11.SG

6.08.2025 г., 23:00 ч. UTC

Печалби

United Overseas Bank 2Q Net S$1.34B Vs. Net S$1.43B >U11.SG

6.08.2025 г., 22:54 ч. UTC

Пазарно говорене

New Zealand Companies Should Avoid Qualifying Profit Improvement -- Market Talk

6.08.2025 г., 22:41 ч. UTC

Печалби

DBS 2Q Allowances for Credit, Other Losses S$133.0M Vs. S$148.0M >D05.SG

6.08.2025 г., 22:38 ч. UTC

Печалби

DBS 2Q Net Interest Income S$3.63B Vs. S$3.77B >D05.SG

6.08.2025 г., 22:38 ч. UTC

Печалби

DBS 2Q Total Income S$5.73B Vs. S$5.48B >D05.SG

6.08.2025 г., 22:38 ч. UTC

Печалби

DBS 2Q Net S$2.82B Vs. Net S$2.80B >D05.SG

6.08.2025 г., 22:28 ч. UTC

Пазарно говорене

NZX Bear Says Growth Likely to Miss Market's Hopes -- Market Talk

6.08.2025 г., 22:11 ч. UTC

Печалби

Pan American Silver 2Q Rev $811.90 >PAAS

6.08.2025 г., 22:11 ч. UTC

Печалби

Pan American Silver Raises Dividend to 12c >PAAS

6.08.2025 г., 22:11 ч. UTC

Печалби

Pan American Silver 2Q EPS 52c >PAAS

6.08.2025 г., 22:03 ч. UTC

Печалби

Nutrien 2Q Sales $10.44B >NTR.T

6.08.2025 г., 22:03 ч. UTC

Печалби

Nutrien: Nitrogen Sales Volume Guidance of 10.7MMT to 11.2MMT Assumes Lower Ammonia Operating Rates in 2H Compared to Record Achieved in 1H Due to Planned Turnaround Activity a North Amer Plants >NTR.T

6.08.2025 г., 22:03 ч. UTC

Печалби

Nutrien: Phosphate Sales Volume Guidance of 2.35MMT to 2.55MMT Assumes Improved Operating Rates, Sales Volumes in 2H Compared to Prior Yr With Completion of Planned Turnarounds in 1H >NTR.T

6.08.2025 г., 22:03 ч. UTC

Печалби

Nutrien: Potash Sales Volume Guidance Was Increased to 13.9MMT to 14.5MMT Due to Expectations for Higher Global Demand in 2025 >NTR.T

6.08.2025 г., 22:03 ч. UTC

Печалби

Nutrien 2Q EPS $2.50 >NTR.T

6.08.2025 г., 22:03 ч. UTC

Придобивния, сливания и поглъщания

A Family Feud Leaves the Future of This Kefir -2-

6.08.2025 г., 22:03 ч. UTC

Придобивния, сливания и поглъщания

A Family Feud Leaves the Future of This Kefir King in Doubt. Danone May Take Over. -- Barrons.com

6.08.2025 г., 22:00 ч. UTC

Пазарно говорене
Печалби

Airbnb 2Q Results Overshadowed by EBITDA Outlook -- Market Talk

6.08.2025 г., 21:53 ч. UTC

Придобивния, сливания и поглъщания

Parataxis Holdings: Combines Bitcoin Exposure, Proprietary Growth Opportunities, Accretive Yield Generation >SBXD

6.08.2025 г., 21:53 ч. UTC

Придобивния, сливания и поглъщания

Parataxis Holdings: Once Proposed Transaction Is Closed, Combined Co Will Be Named Parataxis Holdings Inc. and Seek to Trade on NYSE Under the Symbol 'PRTX' >SBXD

Сравнение с други в отрасъла

Ценова промяна

Phreesia Inc Прогноза

Ценова цел

By TipRanks

17.3% нагоре

12-месечна прогноза

Среден 32 USD  17.3%

Висок 34 USD

Нисък 29 USD

Според 9 анализатори от Wall Street, предложили 12-месечна ценова цел за Phreesia Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

9 ratings

9

Купи

0

Задържане

0

Продай

Техническа оценка

By Trading Central

25.23 / 25.61Подкрепа & съпротива

Краткосрочен план

Neutral Evidence

Средносрочен план

Strong Bullish Evidence

Дългосрочен план

Bullish Evidence

Настроение

By Acuity

76 / 374 Класиране в Здравеопазване

Настроения в новините

Бичи доказателства

Волатилност

Под средното

Обем новини (RCV)

Под средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Phreesia Inc

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, an on-site kiosks. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is based in Wilmington, Delaware.